Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Making tiny plastic particles to deliver lifesaving medicine

29.09.2003


Many medications such as therapeutic DNA, insulin and human growth hormone must enter the body through painful injections, but a Johns Hopkins researcher is seeking to deliver the same treatment without the sting. Justin Hanes wants to pack the drugs inside microscopic plastic spheres that can be inhaled painlessly. Inside the lungs, the particles should dissolve harmlessly, releasing the medicine at a predetermined pace.



"We’ve made significant progress," said Hanes, an assistant professor in the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering, "especially when you consider all of the challenges we’ve faced in designing and synthesizing these new biomaterials."

For one thing, the polymers used in making such particles must dissolve slowly in the body, releasing the medicine over a prescribed period of hours, days or even weeks. Also, these materials must be strong and flexible, so that the particles do not crack or crumble before delivering their treatment. At the same time, the particles must not stick together, forming clumps that will prevent proper travel through the air passages. Once the particles deposit in the lungs, some therapies will require that they cross the thick mucus lining of air passages prior to releasing their medicinal cargo. Finally, the materials must not trigger a strong immune response, in which the body’s natural defense system attacks a particle before it has delivered its dose.


Hanes and his lab colleagues have overcome many of these hurdles, publishing their research results in peer-reviewed journals. Last year, in an issue of "Biomaterials," Hanes’ team, including associate research scientist Jie Fu and doctoral candidate Jennifer Fiegel, reported that it had synthesized a new type of porous polymer particles capable of releasing drugs in an environment resembling the deep lungs. Importantly, the components used to create these plastic microspheres were materials already FDA-approved for other medical applications, making it more likely they will pose no health hazards to humans in their new polymeric form.

Recent work by Hanes, doctoral candidate Michelle Dawson and associate professor Denis Wirtz has focused on understanding how to alter the design of drug-carrying particles so that they can more efficiently cross the mucus lining in the lungs to reach their cell targets underneath. Reports on this work are expected appear shortly in the "Journal of Biology Chemistry," "Biotechnology Progress" and the "Journal of Aerosol Medicine."

Earlier this year, in "Proceedings of the National Academy of Sciences," Hanes, Wirtz and Junghae Suh, a doctoral candidate, reported that their nanoscopic particles appear to be able to efficiently deliver therapeutic genes by carrying DNA directly to the cell nucleus. Someday, Hanes said, this technique also may prove useful in delivering toxic cancer-fighting drugs only to cells affected by the disease.

For his research accomplishments, Hanes is being recognized in the October issue of MIT’s "Technology Review" as one of the world’s top 100 young innovators. The TR100, chosen by the publication’s editors and an elite panel of judges, consists of 100 individuals under 35 whose innovative work in technology has a profound impact on today’s world. Nominees are recognized for their contributions in transforming the nature of technology in industries such as biotechnology, computing, energy, medicine, manufacturing, nanotechnology, telecommunications and transportation. This marks the second consecutive year that a Johns Hopkins engineering faculty member has appeared on the TR100. Last year, the magazine singled out Jennifer Elisseeff, assistant professor of biomedical engineering, for her research in the field of tissue engineering.

Hanes has focused much of his attention on the lungs because they possess several advantages over other drug delivery routes. When medicine is swallowed, it must pass through the stomach, where it may be degraded by digestive acids. Injections may avoid this problem, but they also are painful and may be difficult for some patients to administer to themselves. Inhalation, however, as smokers and asthmatics know, is generally a quick and painless method of getting a drug into the body. Still, Hanes noted, "the lungs are pretty sacred ground. You have to be very conservative about what you put in there."

As a doctoral student at MIT, Hanes played a leading role in developing porous polymer drug delivery particles coated with a special surfactant native to the lung. The surfactant is designed to fool the body into thinking these particles belong in the lungs, warding off an immune response. In 1999, Hanes and his colleagues received a U.S. patent for this invention; Hanes currently holds eight U.S. patents for advanced drug delivery applications.

At Johns Hopkins, he is building upon this research by synthesizing improved inhalation particles, each about a tenth of the diameter of a human hair. He soon hopes to begin testing their safety and effectiveness in animal models and eventually in human trials. Hanes also is trying to produce even smaller particles that could be used to deliver powerful medications directly into diseased cells, while leaving normal tissue unharmed.

Hanes’ early research has been supported by several grants and awards, including one from the Whitaker Foundation.

Phil Sneiderman | EurekAlert!
Further information:
http://www.jhu.edu/
http://www.jhu.edu/~cheme/hanes/index.html
http://www.jhu.edu/chbe/index.asp

More articles from Health and Medicine:

nachricht Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer
26.03.2020 | Johns Hopkins Medicine

nachricht Too much salt weakens the immune system
26.03.2020 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Junior scientists at the University of Rostock invent a funnel for light

Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.

The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.

Im Focus: Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.

Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....

Im Focus: Artificial solid fog material creates pleasant laser light

An international research team led by Kiel University develops an extremely porous material made of "white graphene" for new laser light applications

With a porosity of 99.99 %, it consists practically only of air, making it one of the lightest materials in the world: Aerobornitride is the name of the...

Im Focus: Cross-technology communication in the Internet of Things significantly simplified

Researchers at Graz University of Technology have developed a framework by which wireless devices with different radio technologies will be able to communicate directly with each other.

Whether networked vehicles that warn of traffic jams in real time, household appliances that can be operated remotely, "wearables" that monitor physical...

Im Focus: Peppered with gold

Research team presents novel transmitter for terahertz waves

Terahertz waves are becoming ever more important in science and technology. They enable us to unravel the properties of future materials, test the quality of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“4th Hybrid Materials and Structures 2020” takes place over the internet

26.03.2020 | Event News

Most significant international Learning Analytics conference will take place – fully online

23.03.2020 | Event News

MOC2020: Fraunhofer IOF organises international micro-optics conference in Jena

03.03.2020 | Event News

 
Latest News

3D printer sensors could make breath tests for diabetes possible

27.03.2020 | Power and Electrical Engineering

TU Bergakademie Freiberg researches virus inhibitors from the sea

27.03.2020 | Life Sciences

The Venus flytrap effect: new study shows progress in immune proteins research

27.03.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>